Oncopeptides AB
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden. Show More...
-
Website https://www.oncopeptides.com/sv
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.66 SEK
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share SEK -0.85 -1.6 -3.23 -6.44 -9.58 -14.33 -14.36 Dividends SEK Payout Ratio % * Shares Mil 39.0 39.0 39.0 39.0 43.0 52.0 55.0 Book Value Per Share * SEK 11.98 9.54 17.93 8.23 Free Cash Flow Per Share * SEK -6.82 -6.43 -12.0 Return on Assets % -252.19 -707.23 -381.27 -93.21 -90.76 -103.02 -119.93 Financial Leverage (Average) 1.73 2.11 1.15 1.41 1.25 1.32 Return on Equity % -435.13 -964.29 -112.32 -114.32 -133.12 -148.11 Return on Invested Capital % -435.34 -964.3 -112.32 -114.32 -131.47 -148.11 Interest Coverage Current Ratio 2.35 0.6 1.85 7.95 3.88 5.88 5.04 Quick Ratio 2.18 0.33 1.37 6.74 3.3 5.61 4.99 Debt/Equity